Zogenix (ZGNX) Tops Q1 EPS by 54c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. FND
9. DASH
10. GILD

Go back to Zogenix (ZGNX) Tops Q1 EPS by 54c

Zogenix Provides Corporate Update and Reports First Quarter 2020 Financial Results

May 5, 2020 4:01 PM EDT

FDA PDUFA target action date of June 25, 2020, for FINTEPLA® NDA in Dravet syndromePlan to meet with FDA in second half of 2020 to discuss planned FINTEPLA Lennox-Gastaut syndrome sNDAClosed public offering of common stock for net proceeds of $221.7 million; approximately $420 million in cash and marketable securities at March 31, 2020

EMERYVILLE, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced financial results for the three months ended March 31, 2020, and provided a corporate update. The... More